Breaking News

Flagship Pioneering, Quotient Enter Discovery Pact with Pfizer

Aims to identify potential novel targets for the treatment of cardiovascular and renal diseases.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Flagship Pioneering has further accelerated its strategic partnership with Pfizer with two research programs with Flagship-founded Quotient Therapeutics. Under the collaboration, the companies will analyze somatic mutations that occur in diseased patient tissue to inform the discovery and development of potentially transformative therapies for cardiovascular and renal diseases.   Pioneering Medicines, Flagship’s in house drug discovery and development unit, will lead the strategic partne...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters